What question did this study set out to answer?

This research aims to investigate the levels of asprosin and subfatin in non-obese women with PCOS.

February 22, 2026Endokrynologia PolskaOpen Access

Asprosin, but not subfatin, associated with non-obese polycystic ovary syndrome

View Full Paper

Ask AI

Bookmark

This research aims to investigate the levels of asprosin and subfatin in non-obese women with PCOS.
Analyzed blood samples from non-obese women diagnosed with PCOS.
Measured levels of asprosin and subfatin to compare with control group.
Assessed the relationship between asprosin levels and insulin resistance.
Asprosin levels were significantly higher in women with PCOS compared to controls.
Subfatin levels showed no significant differences between groups.
Elevated asprosin may act as a marker for PCOS independent of insulin resistance.

Implication

Finds asprosin significantly elevated in women with PCOS, suggesting it as a key biomarker.

Abstract

Asprosin, but not subfatin, was significantly elevated in non-obese women with PCOS. It may serve as a marker of PCOS independent of insulin resistance in normal-weight women.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Baran et al. (2026) studied this question.

synapsesocial.com/papers/699a9ceb482488d673cd2a45 https://doi.org/10.5603/ep.108447

View Full Paper

Ask AI

Bookmark

Implication

Finds asprosin significantly elevated in women with PCOS, suggesting it as a key biomarker.

Abstract

Asprosin, but not subfatin, was significantly elevated in non-obese women with PCOS. It may serve as a marker of PCOS independent of insulin resistance in normal-weight women.

Asprosin, but not subfatin, associated with non-obese polycystic ovary syndrome

Key Points

Implication

Abstract

Discussion

Cite This Study

Asprosin, but not subfatin, associated with non-obese polycystic ovary syndrome

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading